# Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI

> **NCT02576600** · NA · COMPLETED · sponsor: **Pr Isabelle CONSTANT** · enrollment: 65 (actual)

## Conditions studied

- Pain

## Interventions

- **DEVICE:** Videopupillometer Algiscan
- **OTHER:** Standard practice
- **DRUG:** Propofol
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT02576600
- **Lead sponsor:** Pr Isabelle CONSTANT
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2015-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576600, "Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT02576600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*